Acebutolol Hydrochloride Capsule
Product Images NDC 42291-010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Acebutolol Hydrochloride (NDC 42291-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 (010 01)

100 (010 01)
Packaging label for Acebutolol Hydrochloride Capsules, USP 200 mg by AvKARE. The label shows the dosage form as capsules, with a package size of 100 capsules. It includes regulatory information such as Rx Only and storage instructions, along with the NDC number 42291-010-01.*
FDA Label Image

F1931f84-figure-01 (Acebutolol HCl Capsules Usp India 1)

F1931f84-figure-01 (Acebutolol HCl Capsules Usp   India 1)
Chemical structure diagram of Acebutolol Hydrochloride, showing its molecular components and arrangement including functional groups and bonds.*
FDA Label Image

F1931f84-figure-02 (Acebutolol HCl Capsules Usp India 2)

F1931f84-figure-02 (Acebutolol HCl Capsules Usp   India 2)
A data table presenting the percentages of adverse reactions reported in U.S. studies for Acebutolol, Propranolol, Hydrochlorothiazide, and Placebo. The table categorizes adverse reactions by body system, including cardiovascular, central nervous system, dermatologic, gastrointestinal, genitourinary, musculoskeletal, respiratory, and special senses, showing comparative frequencies among the four groups.*
FDA Label Image

F1931f84-figure-03 (Acebutolol HCl Capsules Usp India 3)

F1931f84-figure-03 (Acebutolol HCl Capsules Usp   India 3)
A data table showing adverse event percentages categorized by body system for three dosage groups (400 mg/day, 800 mg/day, 1200 mg/day) in a clinical study involving 132, 63, and 71 subjects respectively. The body systems listed include cardiovascular, gastrointestinal, musculoskeletal, central nervous system, respiratory, skin, special senses, and genitourinary.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.